News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
562,408 Results
Type
Article (40703)
Company Profile (77)
Press Release (521628)
Multimedia
Podcasts (50)
Webinars (13)
Section
Business (155337)
Career Advice (2438)
Deals (28293)
Drug Delivery (98)
Drug Development (73312)
Employer Resources (141)
FDA (14349)
Job Trends (12389)
News (276670)
Policy (27438)
Tag
Academia (2561)
Academic (1)
Accelerated approval (8)
Adcomms (27)
Allergies (90)
Alliances (39172)
ALS (109)
Alzheimer's disease (1449)
Antibody-drug conjugate (ADC) (154)
Approvals (14335)
Artificial intelligence (283)
Autoimmune disease (29)
Automation (17)
Bankruptcy (315)
Best Places to Work (10110)
BIOSECURE Act (15)
Biosimilars (102)
Biotechnology (61)
Bladder cancer (92)
Brain cancer (35)
Breast cancer (350)
Cancer (2738)
Cardiovascular disease (216)
Career advice (2051)
Career pathing (32)
CAR-T (173)
CDC (27)
Cell therapy (461)
Cervical cancer (19)
Clinical research (60600)
Collaboration (863)
Company closure (3)
Compensation (358)
Complete response letters (23)
COVID-19 (2496)
CRISPR (53)
C-suite (334)
Cystic fibrosis (95)
Data (2876)
Decentralized trials (2)
Denatured (6)
Depression (67)
Diabetes (330)
Diagnostics (5785)
Digital health (20)
Diversity (5)
Diversity, equity & inclusion (39)
Drug discovery (123)
Drug pricing (113)
Drug shortages (25)
Duchenne muscular dystrophy (118)
Earnings (57421)
Editorial (41)
Employer branding (18)
Employer resources (130)
Events (78065)
Executive appointments (852)
FDA (15887)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (820)
Gene editing (121)
Generative AI (22)
Gene therapy (369)
GLP-1 (756)
Government (4218)
Grass and pollen (5)
Guidances (177)
Healthcare (16595)
Huntington's disease (30)
IgA nephropathy (42)
Immunology and inflammation (162)
Immuno-oncology (7)
Indications (37)
Infectious disease (2667)
Inflammatory bowel disease (140)
Inflation Reduction Act (10)
Influenza (62)
Intellectual property (110)
Interviews (523)
IPO (12830)
IRA (45)
Job creations (2639)
Job search strategy (1676)
Kidney cancer (15)
Labor market (31)
Layoffs (447)
Leadership (25)
Legal (5879)
Liver cancer (77)
Lung cancer (403)
Lymphoma (197)
Machine learning (10)
Management (51)
Manufacturing (314)
MASH (98)
Medical device (11658)
Medtech (11662)
Mergers & acquisitions (16095)
Metabolic disorders (818)
Multiple sclerosis (95)
NASH (23)
Neurodegenerative disease (119)
Neuropsychiatric disorders (37)
Neuroscience (2121)
NextGen: Class of 2025 (5672)
Non-profit (4032)
Now hiring (38)
Obesity (400)
Opinion (223)
Ovarian cancer (96)
Pain (108)
Pancreatic cancer (118)
Parkinson's disease (178)
Partnered (18)
Patents (279)
Patient recruitment (152)
Peanut (45)
People (51785)
Pharmaceutical (22)
Pharmacy benefit managers (13)
Phase I (18647)
Phase II (26661)
Phase III (20315)
Pipeline (1564)
Policy (186)
Postmarket research (2328)
Preclinical (7646)
Press Release (54)
Prostate cancer (132)
Psychedelics (42)
Radiopharmaceuticals (223)
Rare diseases (441)
Real estate (4209)
Recruiting (57)
Regulatory (19700)
Reports (29)
Research institute (2140)
Resumes & cover letters (357)
Rett syndrome (10)
RNA editing (7)
RSV (45)
Schizophrenia (92)
Series A (139)
Series B (93)
Service/supplier (4)
Sickle cell disease (60)
Special edition (13)
Spinal muscular atrophy (146)
Sponsored (31)
Startups (2810)
State (2)
Stomach cancer (15)
Supply chain (62)
Tariffs (45)
The Weekly (43)
Vaccines (723)
Venture capital (43)
Weight loss (251)
Women's health (34)
Worklife (17)
Date
Last 7 days (323)
Last 30 days (1630)
Last 365 days (27576)
2025 (14733)
2024 (31004)
2023 (34725)
2022 (45219)
2021 (48500)
2020 (47055)
2019 (40419)
2018 (30647)
2017 (27571)
2016 (26255)
2015 (30765)
2014 (23155)
2013 (18924)
2012 (20244)
2011 (21102)
2010 (18730)
Location
Africa (725)
Alabama (56)
Alaska (5)
Arizona (158)
Arkansas (11)
Asia (34515)
Australia (7107)
California (6206)
Canada (2128)
China (610)
Colorado (273)
Connecticut (251)
Delaware (174)
Europe (76976)
Florida (1009)
Georgia (222)
Idaho (52)
Illinois (583)
India (23)
Indiana (315)
Iowa (13)
Japan (209)
Kansas (94)
Kentucky (23)
Louisiana (12)
Maine (50)
Maryland (890)
Massachusetts (4418)
Michigan (219)
Minnesota (354)
Mississippi (2)
Missouri (82)
Montana (25)
Nebraska (22)
Nevada (73)
New Hampshire (68)
New Jersey (1848)
New Mexico (21)
New York (1804)
North Carolina (900)
North Dakota (6)
Northern California (2720)
Ohio (201)
Oklahoma (9)
Oregon (29)
Pennsylvania (1368)
Puerto Rico (17)
Rhode Island (29)
South America (998)
South Carolina (30)
South Dakota (1)
Southern California (2379)
Tennessee (104)
Texas (974)
United States (23239)
Utah (202)
Virginia (169)
Washington D.C. (59)
Washington State (537)
West Virginia (4)
Wisconsin (50)
562,408 Results for "asensus surgical formerly known as transenterix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Asensus Surgical Announces Signing of Definitive Merger Agreement with KARL STORZ
Asensus Surgical, Inc. today announced that it has entered into a definitive merger agreement (the “Merger Agreement”) with KARL STORZ Endoscopy-America, Inc.
June 7, 2024
·
7 min read
Bio NC
Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference.
February 28, 2024
·
1 min read
Business
Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2024
Asensus Surgical, Inc., a global leader of innovative digital solutions for the operating room, announced its operating and financial results for the first quarter 2024.
May 14, 2024
·
15 min read
Bio NC
Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program
Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient, announced that Sendai Tokushukai Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System.
April 29, 2024
·
4 min read
Bio NC
Asensus Surgical Announces St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan to Initiate Senhance Surgery Program
Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.
June 24, 2024
·
5 min read
Bio NC
Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System
Asensus Surgical, Inc. announced a key development milestone for LUNA™, the Company’s second-generation surgical robotic system.
January 4, 2024
·
5 min read
Bio NC
Asensus Surgical, Inc. Announces Agreement with Flex for Design and Advanced Manufacturing Services for the LUNA™ Surgical System
Asensus Surgical, Inc. announced an agreement with diversified manufacturer Flex for design and advanced manufacturing services for Asensus’s previously-announced LUNA Surgical System, a next-generation surgical robot platform.
November 13, 2023
·
4 min read
Business
Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024
Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient, announced that it plans to release 2024 first quarter financial and operating results after the market closes on Tuesday, May 14, 2024.
May 7, 2024
·
1 min read
Bio NC
Senhance Robotic System Sold by Asensus Surgical
Asensus Surgical, Inc. announced that a Senhance® Surgical System has been sold to the Company’s distribution partner and will be placed in a hospital in the Commonwealth of Independent States region.
December 4, 2023
·
3 min read
Bio NC
Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals
Asensus Surgical, Inc. announced the completion of more than 1,000 successful cases each at three hospitals utilizing the Senhance® Surgical System: Klaipeda University Hospital, Presidential Clinic Astana, and Evangelisches Krankenhaus Wesel GmbH.
February 27, 2024
·
3 min read
1 of 56,241
Next
